ATE131733T1 - Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese - Google Patents

Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese

Info

Publication number
ATE131733T1
ATE131733T1 AT91908337T AT91908337T ATE131733T1 AT E131733 T1 ATE131733 T1 AT E131733T1 AT 91908337 T AT91908337 T AT 91908337T AT 91908337 T AT91908337 T AT 91908337T AT E131733 T1 ATE131733 T1 AT E131733T1
Authority
AT
Austria
Prior art keywords
fatty acids
iontophoresis
medication
administration
producing
Prior art date
Application number
AT91908337T
Other languages
English (en)
Inventor
Rama V Padmanabhan
Joan M Sunram
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE131733T1 publication Critical patent/ATE131733T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91908337T 1990-04-18 1991-04-15 Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese ATE131733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51050290A 1990-04-18 1990-04-18

Publications (1)

Publication Number Publication Date
ATE131733T1 true ATE131733T1 (de) 1996-01-15

Family

ID=24031010

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908337T ATE131733T1 (de) 1990-04-18 1991-04-15 Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese

Country Status (16)

Country Link
EP (1) EP0525063B1 (de)
JP (1) JP3261501B2 (de)
AT (1) ATE131733T1 (de)
AU (1) AU650879B2 (de)
CA (1) CA2078998A1 (de)
DE (1) DE69115687T2 (de)
DK (1) DK0525063T3 (de)
ES (1) ES2081476T3 (de)
FI (1) FI924724A0 (de)
GR (1) GR3018883T3 (de)
IE (1) IE73245B1 (de)
NO (1) NO924029D0 (de)
NZ (1) NZ237489A (de)
PT (1) PT97410B (de)
WO (1) WO1991016077A1 (de)
ZA (1) ZA912192B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002232A1 (en) * 1994-07-13 1996-02-01 Alza Corporation Composition and method for enhancing transdermal electrotransport agent delivery
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US5985316A (en) * 1995-04-28 1999-11-16 Alza Corporation Composition and method of enhancing electrotransport agent delivery
US6757560B1 (en) 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
DE19816143A1 (de) 1998-04-09 1999-10-21 Fischer Wilfried Transdermales Applikationssystem (TDS) mit Elektrodenraster
EP1457233B1 (de) 2003-03-12 2007-07-11 Novosis AG Transdermales Wirkstoffverabreichungssystem mit Elektrodenraster
DE102007020799A1 (de) 2007-05-03 2008-11-06 Novosis Ag Transdermales therapeutisches System mit Remifentanil
DE102007021549A1 (de) 2007-05-08 2008-11-13 Novosis Ag Transdermales therapeutisches System enthaltend mindestens zwei Opioide
DE102007058504A1 (de) 2007-12-05 2009-07-09 Acino Ag Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR)
DE102010024558B4 (de) 2010-06-22 2016-04-21 Amw Gmbh Transdermales therapeutisches System mit Elektroden
CN115436538B (zh) * 2022-09-17 2023-08-01 山东省计量科学研究院 一种肉类食品基体兽药残留标准物质制备装置与方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
EP0375689B1 (de) * 1987-06-01 1992-08-12 Warner-Lambert Company Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids.
EP0351897A3 (de) * 1988-06-17 1990-03-21 The Procter & Gamble Company Hautpenetrierendes System für aminfunktionelle Anrzneistoffsalze

Also Published As

Publication number Publication date
FI924724A (fi) 1992-10-19
DE69115687T2 (de) 1996-07-18
AU7750091A (en) 1991-11-11
EP0525063A1 (de) 1993-02-03
GR3018883T3 (en) 1996-05-31
FI924724A0 (fi) 1992-10-19
JP3261501B2 (ja) 2002-03-04
EP0525063B1 (de) 1995-12-20
AU650879B2 (en) 1994-07-07
ES2081476T3 (es) 1996-03-16
ZA912192B (en) 1992-01-29
JPH05506232A (ja) 1993-09-16
IE911280A1 (en) 1991-10-23
DK0525063T3 (da) 1996-01-29
PT97410A (pt) 1992-01-31
NZ237489A (en) 1995-07-26
CA2078998A1 (en) 1991-10-19
IE73245B1 (en) 1997-05-21
NO924029L (no) 1992-10-16
WO1991016077A1 (en) 1991-10-31
DE69115687D1 (de) 1996-02-01
PT97410B (pt) 1998-08-31
NO924029D0 (no) 1992-10-16

Similar Documents

Publication Publication Date Title
SE8404243L (sv) Forfarande och anordning for elektro-terapeutisk behandling
SE8703625D0 (sv) New medical use
ATE122899T1 (de) Verfahren und gegenstand zur transdermalen administration von dexmedetomidin.
ES2000428T3 (es) Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
DE3856306D1 (de) Verfahren zur Herstellung von Applikatoren zur transdermalen Verabreichung von Medikamenten
DE3585618D1 (de) Anregung zur heilung einer wunde mittels menschlichen hautwachstumsfaktors hergestellt durch rekombinant-dns.
ATE131733T1 (de) Verwendung von spezifischen fettsäuren zur herstellung eines medikaments zur verabreichung durch iontophorese
EP0299756A3 (en) Anti-acne composition
ATE18353T1 (de) Verfahren zur herstellung von liposomenloesungen.
DE3667610D1 (de) System zur verabreichung von substanzen durch die haut.
ATA160487A (de) Verfahren zur herstellung eines transdermalen therapeutischen membransystems mit diclofenac
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
AU7426487A (en) Method of treating depression using d-fenfluramine
DE58908604D1 (de) Medizinisches Gerät zur Stimulation eines physiologischen Vorganges eines Lebewesens mit sich selbsttätig an die körperliche Aktivität des Lebewesens anpassender Stimulationsintensiät.
ES8201535A1 (es) Un procedimiento para la preparacion de nuevos acil-deriva- dos de carnitina
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
DE3280277D1 (de) Verfahren zur herstellung eines spezifisch auf das ernaehrungszentrum wirkenden appetitregelnden wirkstoffes sowie der nach diesem verfahren erhaeltliche wirkstoff.
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
ATE28384T1 (de) Medizinisches verfahren und zubereitung.
AT386121B (de) Verfahren zur herstellung eines pharmazeutischen praeparates
ATA386679A (de) Verfahren zum herstellen von 3-pyrrolin-2-onen bzw. von pyrrolidin-2-onen, von optisch aktiven isomeren und cis- bzw. trans-isomeren hievon
ATE58831T1 (de) Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time